{"product_id":"perfusion-for-congenital-heart-surgery-isbn-9781118900796","title":"Perfusion for Congenital Heart Surgery","description":"\u003cp\u003e\u003cb\u003eA complete guide to the tools and techniques for modeling, simulating, and optimizing SSFE processes and phenomena\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eIn \u003ci\u003eModeling, Simulation, and Optimization of Supercritical and Subcritical Fluid Extraction Processes,\u003c\/i\u003e a team of expert chemical engineers delivers a comprehensive guide to the tools and techniques used to model supercritical and subcritical fluid extraction (SSFE) processes and phenomena. The book offers details on SSFE experiment management, as well as modeling and optimization of SSFE. \u003c\/p\u003e\u003cp\u003eThe authors begin with a discussion of the fundamentals of SSFE and the necessary experimental techniques to validate the models. They also discuss process simulators, conventional optimization techniques, and state-of-the-art genetic algorithm methods. \u003c\/p\u003e\u003cp\u003eSeveral practical examples and case studies on SSFE modeling and optimization techniques are provided. Additionally, detailed thermodynamic modeling with and without co-solvent and non-equilibrium system modeling are covered. \u003c\/p\u003e\u003cp\u003eReaders will also find: \u003c\/p\u003e\u003cul\u003e\n\u003cli\u003eA detailed overview of the field of supercritical and subcritical fluid extraction and their importance to the food, cosmetics, and pharmaceutical industries\u003c\/li\u003e \u003cli\u003eExplorations of the concepts and methodologies for modeling, simulation, and optimization of SSFE, including conservation laws related to SSFE traditional first principle modeling\u003c\/li\u003e \u003cli\u003ePractical discussions of the characteristics and physical properties of palm oil as a solute and descriptions of some existing palm oil industrial processes\u003c\/li\u003e \u003cli\u003eAn examination of first principle methodology as applied to the modeling of the properties of palm oil components and mixtures\u003c\/li\u003e\n\u003c\/ul\u003e \u003cp\u003ePerfect for researchers, scientists, technologists, and engineers working in food science and the pharmaceutical, cosmetic, and agricultural industries, \u003ci\u003eModeling, Simulation, and Optimization of Supercritical and Subcritical Fluid Extraction Processes\u003c\/i\u003e is also a must-read for those working with process design, development, quality control, and improvement in the chemical industries. \u003c\/p\u003e\u003cp\u003eForeword, x\u003c\/p\u003e \u003cp\u003ePreface, xi\u003c\/p\u003e \u003cp\u003eAcknowledgments, xii\u003c\/p\u003e \u003cp\u003e\u003cb\u003e1 Equipment for bypass, 1\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eOxygenators, 1\u003c\/p\u003e \u003cp\u003eArterial line filters, 12\u003c\/p\u003e \u003cp\u003eTubing packs, 13\u003c\/p\u003e \u003cp\u003eCardioplegia systems, 16\u003c\/p\u003e \u003cp\u003eThe heart–lung machine, 17\u003c\/p\u003e \u003cp\u003eThe heater-cooler system, 19\u003c\/p\u003e \u003cp\u003eCannulae, 20\u003c\/p\u003e \u003cp\u003e\u003cb\u003e2 Priming the bypass circuit, 27\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003ePrime constituents, 27\u003c\/p\u003e \u003cp\u003eSteps for priming, 28\u003c\/p\u003e \u003cp\u003e\u003cb\u003e3 The bypass plan, 33\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eCommunication agreement for case, 33\u003c\/p\u003e \u003cp\u003eAnticoagulation management, 35\u003c\/p\u003e \u003cp\u003eBlood gas management, 40\u003c\/p\u003e \u003cp\u003eCarbon dioxide management, 40\u003c\/p\u003e \u003cp\u003eOxygenation strategy, 42\u003c\/p\u003e \u003cp\u003eHematocrit management, 45\u003c\/p\u003e \u003cp\u003eBlood pressure management, 47\u003c\/p\u003e \u003cp\u003eTemperature management, 49\u003c\/p\u003e \u003cp\u003eFlow rates, regional perfusion, and hypothermic circulatory arrest, 52\u003c\/p\u003e \u003cp\u003eMethods of ultrafiltration, 55\u003c\/p\u003e \u003cp\u003eBefore bypass, 55\u003c\/p\u003e \u003cp\u003eOn bypass, 55\u003c\/p\u003e \u003cp\u003eAfter bypass, 56\u003c\/p\u003e \u003cp\u003eSMUF specifications, 59\u003c\/p\u003e \u003cp\u003eStandard and augmented venous return, 60\u003c\/p\u003e \u003cp\u003eStandard venous return with gravity siphon drainage, 60\u003c\/p\u003e \u003cp\u003eAugmented venous return, 60\u003c\/p\u003e \u003cp\u003eThe prebypass checklist, 63\u003c\/p\u003e \u003cp\u003eThe surgical safety checklist for congenital heart surgery, 65\u003c\/p\u003e \u003cp\u003e\u003cb\u003e4 Typical phases of cardiopulmonary bypass, 72\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eCommencement of bypass, 72\u003c\/p\u003e \u003cp\u003eStandard support phase of bypass, 74\u003c\/p\u003e \u003cp\u003eTermination of bypass, 76\u003c\/p\u003e \u003cp\u003ePost bypass, 78\u003c\/p\u003e \u003cp\u003e\u003cb\u003e5 Additional notes based on bypass tasks, 79\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003ePrebypass, 79\u003c\/p\u003e \u003cp\u003eHeart–lung machine (HLM), 79\u003c\/p\u003e \u003cp\u003eReoperations, 79\u003c\/p\u003e \u003cp\u003eCannulation, 79\u003c\/p\u003e \u003cp\u003eTransfusion during cannulation, 80\u003c\/p\u003e \u003cp\u003eOn bypass, 80\u003c\/p\u003e \u003cp\u003eVerification of adequate drainage when caval tapes are used, 80\u003c\/p\u003e \u003cp\u003eBlood gas management, 80\u003c\/p\u003e \u003cp\u003eCardioplegia delivery, 81\u003c\/p\u003e \u003cp\u003ePlanned circulatory arrest, 81\u003c\/p\u003e \u003cp\u003eInduced ventricular fibrillation, 82\u003c\/p\u003e \u003cp\u003eAdministration of blood products, 82\u003c\/p\u003e \u003cp\u003eAtrial line placement, 82\u003c\/p\u003e \u003cp\u003eLV vent placement, 83\u003c\/p\u003e \u003cp\u003eBed rotation during bypass, 83\u003c\/p\u003e \u003cp\u003e\u003cb\u003e6 Bypass considerations based on diagnosis, 85\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eAnomalous coronary arteries, 86\u003c\/p\u003e \u003cp\u003eAortic regurgitation\/insufficiency, 89\u003c\/p\u003e \u003cp\u003eAortic stenosis, 91\u003c\/p\u003e \u003cp\u003eAortopulmonary collaterals, 93\u003c\/p\u003e \u003cp\u003eAortopulmonary window, 95\u003c\/p\u003e \u003cp\u003eAtrial septal defect, 96\u003c\/p\u003e \u003cp\u003eCardiomyopathy requiring orthotopic heart transplantation, 99\u003c\/p\u003e \u003cp\u003eCoarctation of the aorta, 100\u003c\/p\u003e \u003cp\u003eCommon atrioventricular canal defect, 102\u003c\/p\u003e \u003cp\u003eCor triatriatum, 104\u003c\/p\u003e \u003cp\u003eCorrected transposition of the great arteries (L-TGA, Levo-TGA, or C-TGA) or congenitally corrected TGA, 105\u003c\/p\u003e \u003cp\u003eCritical aortic stenosis, 107\u003c\/p\u003e \u003cp\u003eDouble chambered right ventricle, 109\u003c\/p\u003e \u003cp\u003eDouble inlet left ventricle, 110\u003c\/p\u003e \u003cp\u003eDouble outlet left ventricle, 111\u003c\/p\u003e \u003cp\u003eDouble outlet right ventricle, 112\u003c\/p\u003e \u003cp\u003eEbstein’s anomaly, 113\u003c\/p\u003e \u003cp\u003eHypoplastic left heart syndrome, 114\u003c\/p\u003e \u003cp\u003eStage 1 (Norwood) procedure, 115\u003c\/p\u003e \u003cp\u003eHybrid stage 1 palliation, 117\u003c\/p\u003e \u003cp\u003eStage 2 or bidirectional Glenn shunt, 117\u003c\/p\u003e \u003cp\u003eFontan procedure (total cavopulmonary anastomosis), 119\u003c\/p\u003e \u003cp\u003eInterrupted aortic arch, 121\u003c\/p\u003e \u003cp\u003eLeft superior vena cava, 123\u003c\/p\u003e \u003cp\u003eLung transplantation, 124\u003c\/p\u003e \u003cp\u003eMitral regurgitation\/insufficiency, 125\u003c\/p\u003e \u003cp\u003eMitral stenosis, 126\u003c\/p\u003e \u003cp\u003ePatent ductus arteriosus, 127\u003c\/p\u003e \u003cp\u003ePulmonary artery abnormalities, 128\u003c\/p\u003e \u003cp\u003ePulmonary atresia, 129\u003c\/p\u003e \u003cp\u003ePulmonary atresia with an intact ventricular septum, 129\u003c\/p\u003e \u003cp\u003ePulmonary atresia with ventricular septal defect, 130\u003c\/p\u003e \u003cp\u003ePulmonary regurgitation\/insufficiency, 132\u003c\/p\u003e \u003cp\u003ePulmonary stenosis, 133\u003c\/p\u003e \u003cp\u003ePulmonary vein stenosis or pulmonary venous obstruction, 134\u003c\/p\u003e \u003cp\u003eTetralogy of Fallot, 136\u003c\/p\u003e \u003cp\u003eTotal anomalous pulmonary venous return and partial anomalous pulmonary venous return, 138\u003c\/p\u003e \u003cp\u003ed-Transposition of the great arteries, 140\u003c\/p\u003e \u003cp\u003eTricuspid atresia, 142\u003c\/p\u003e \u003cp\u003eTricuspid regurgitation\/insufficiency, 143\u003c\/p\u003e \u003cp\u003eTruncus arteriosus, 144\u003c\/p\u003e \u003cp\u003eVentricular septal defect, 146\u003c\/p\u003e \u003cp\u003e\u003cb\u003e7 Notes on select issues during bypass, 148\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eBlood pressure higher than expected, 148\u003c\/p\u003e \u003cp\u003eBlood pressure lower than expected, 149\u003c\/p\u003e \u003cp\u003eBypass circuit pressure higher than expected, 151\u003c\/p\u003e \u003cp\u003eBypass circuit pressure lower than expected, 152\u003c\/p\u003e \u003cp\u003eCentral venous pressure elevated, 153\u003c\/p\u003e \u003cp\u003eHeat exchange issue (slow cooling or warming), 154\u003c\/p\u003e \u003cp\u003eNIRS values lower than expected, 155\u003c\/p\u003e \u003cp\u003ePaCO\u003csub\u003e2\u003c\/sub\u003e higher than expected, 157\u003c\/p\u003e \u003cp\u003ePaCO\u003csub\u003e2\u003c\/sub\u003e lower than expected, 159\u003c\/p\u003e \u003cp\u003ePaO\u003csub\u003e2\u003c\/sub\u003e lower than expected, 160\u003c\/p\u003e \u003cp\u003eReservoir volume acutely low, 161\u003c\/p\u003e \u003cp\u003e\u003cb\u003e8 Notes on select emergency procedures during bypass, 163\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eArterial pump failure (roller head), 164\u003c\/p\u003e \u003cp\u003eFailure to oxygenate, 165\u003c\/p\u003e \u003cp\u003eMassive air embolization, 166\u003c\/p\u003e \u003cp\u003eAcute aortic dissection at the initiation of bypass, 168\u003c\/p\u003e \u003cp\u003eVenous air lock, 169\u003c\/p\u003e \u003cp\u003eInadvertent arterial decannulation, 170\u003c\/p\u003e \u003cp\u003eInadvertent venous decannulation, 171\u003c\/p\u003e \u003cp\u003e\u003cb\u003e9 Brief overview of named procedures and terms, 172\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eAlfieri stitch, 172\u003c\/p\u003e \u003cp\u003eBatista procedure, 172\u003c\/p\u003e \u003cp\u003eBentall procedure, 172\u003c\/p\u003e \u003cp\u003eBidirectional Glenn shunt, 172\u003c\/p\u003e \u003cp\u003eBlalock–Hanlon procedure, 172\u003c\/p\u003e \u003cp\u003eBlalock–Taussig shunt (BTS), 173\u003c\/p\u003e \u003cp\u003eBrock procedure, 173\u003c\/p\u003e \u003cp\u003eCentral shunt, 173\u003c\/p\u003e \u003cp\u003eCone procedure, 173\u003c\/p\u003e \u003cp\u003eCox maze procedure, 173\u003c\/p\u003e \u003cp\u003eDamus–Kaye–Stansel anastomosis, 173\u003c\/p\u003e \u003cp\u003eDouble switch procedure, 173\u003c\/p\u003e \u003cp\u003eFontan procedure, 174\u003c\/p\u003e \u003cp\u003eGott shunt, 174\u003c\/p\u003e \u003cp\u003eHemi–Fontan procedure, 174\u003c\/p\u003e \u003cp\u003eHolmes heart, 174\u003c\/p\u003e \u003cp\u003eJatene operation, 174\u003c\/p\u003e \u003cp\u003eKawasaki disease, 174\u003c\/p\u003e \u003cp\u003eKawashima procedure, 175\u003c\/p\u003e \u003cp\u003e(Diverticulum of) Kommerell, 175\u003c\/p\u003e \u003cp\u003eKonno procedure, 175\u003c\/p\u003e \u003cp\u003eLeCompte maneuver, 175\u003c\/p\u003e \u003cp\u003eLeCompte procedure, 175\u003c\/p\u003e \u003cp\u003eManougian procedure, 175\u003c\/p\u003e \u003cp\u003eMarfan’s syndrome, 175\u003c\/p\u003e \u003cp\u003eMaze procedure, 175\u003c\/p\u003e \u003cp\u003eMustard procedure, 176\u003c\/p\u003e \u003cp\u003eNicks procedure, 176\u003c\/p\u003e \u003cp\u003eNikaidoh procedure, 176\u003c\/p\u003e \u003cp\u003eNoonan syndrome, 176\u003c\/p\u003e \u003cp\u003eNorwood operation, 176\u003c\/p\u003e \u003cp\u003ePannus, 176\u003c\/p\u003e \u003cp\u003ePentalogy of Cantrell, 176\u003c\/p\u003e \u003cp\u003ePotts shunt, 177\u003c\/p\u003e \u003cp\u003eRashkind procedure, 177\u003c\/p\u003e \u003cp\u003eRastelli operation, 177\u003c\/p\u003e \u003cp\u003eRoss procedure, 177\u003c\/p\u003e \u003cp\u003eSano shunt, 177\u003c\/p\u003e \u003cp\u003eScimitar syndrome, 177\u003c\/p\u003e \u003cp\u003eSenning operation, 177\u003c\/p\u003e \u003cp\u003eShone’s complex, 178\u003c\/p\u003e \u003cp\u003eTakeuchi procedure, 178\u003c\/p\u003e \u003cp\u003eTaussig–Bing anomaly, 178\u003c\/p\u003e \u003cp\u003eTrusler repair, 178\u003c\/p\u003e \u003cp\u003eVan Praagh classification, 178\u003c\/p\u003e \u003cp\u003eWarden procedure, 178\u003c\/p\u003e \u003cp\u003eWaterston shunt, 178\u003c\/p\u003e \u003cp\u003eWilliams syndrome, 178\u003c\/p\u003e \u003cp\u003eYasui procedure, 179\u003c\/p\u003e \u003cp\u003e\u003cb\u003e10 Abbreviations for congenital heart surgery, 180\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e11 Recommended reference books, 186\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e12 Comprehensive experience-based equipment selection chart select medications administered during bypass, 187\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eIndex, 190\u003c\/p\u003e \u003cp\u003e\u003cb\u003eGREGORY S. MATTE\u003cbr\u003ePerfusion Clinical Coordinator (Co-Chief)\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eBoston Children’s Hospital, Boston, MA, USA\u003c\/i\u003e\u003c\/p\u003e  \u003cp\u003e\u003cb\u003ePerfusion for Congenital Heart Surgery\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eThe art and science of providing perfusion for patients undergoing surgical correction of congenital heart lesions has advanced rapidly in the last decade. The complex equipment, the unique acid–base management strategies, the specialized perfusion and ultrafiltration techniques, the wide variation in patient’s age, size, and vulnerability to physiologic trespass, and the wide variety of surgical procedures performed set perfusion for congenital heart surgery apart from that provided for correction of acquired heart disease in adults. Consequently, provision of cardiopulmonary support for repair of congenital heart lesions has become a distinct specialty.  \u003c\/p\u003e\u003cp\u003e\u003ci\u003ePerfusion for Congenital Heart Surgery\u003c\/i\u003e provides an invaluable road map for the pediatric perfusionist and non-perfusionist caring for patients with congenital heart disease (CHD) in order to confidently devise a plan for a pump run. The easily referenced information and reminders, not currently readily available in any other publication, can be used to influence a bypass plan and form an essential resource for perfusionists, anesthesiologists, intensivists, and other clinicians caring for patients with CHD.  \u003c\/p\u003e\u003cp\u003e This practical, spiral-bound, go-to reference is designed to answer the most frequently posed questions about bypass for CHD, the surgical treatment of which is often complicated, with some conditions seen only rarely in practice. \u003c\/p\u003e\u003cp\u003e\u003ci\u003ePerfusion for Congenital Heart Surgery\u003c\/i\u003e is written and designed for regular use and has the following features:   \u003c\/p\u003e\u003cul\u003e\n\u003cli\u003eFocuses on the latest devices and techniques and provides clear, matter-of-fact guidance on their roles and importance to CHD procedures\u003c\/li\u003e \u003cli\u003eWritten by a seasoned perfusionist who is co-chief and educator at one of the world’s leading children’s hospitals\u003c\/li\u003e \u003cli\u003eThe spiral binding allows the book to be laid flat for easy referral\u003c\/li\u003e \u003cli\u003eA “Notes” section, following the discussion of each CHD lesion, enables readers to add institution and\/or surgeon-specific information for later reference\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"Wiley-Blackwell","offers":[{"title":"Default Title","offer_id":47989765865701,"sku":"NP9781118900796","price":187.95,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1842\/7735\/files\/9781118900796.jpg?v=1761785394","url":"https:\/\/k12savings.com\/es\/products\/perfusion-for-congenital-heart-surgery-isbn-9781118900796","provider":"K12savings","version":"1.0","type":"link"}